Published in PLoS One on December 07, 2012
An Update on the Use of Animal Models in Diabetic Nephropathy Research. Curr Diab Rep (2016) 0.89
Biomarkers of rapid chronic kidney disease progression in type 2 diabetes. Kidney Int (2015) 0.87
Chronic Running Exercise Alleviates Early Progression of Nephropathy with Upregulation of Nitric Oxide Synthases and Suppression of Glycation in Zucker Diabetic Rats. PLoS One (2015) 0.77
C-Peptide-based assessment of insulin secretion in the Zucker Fatty rat: a modelistic study. PLoS One (2015) 0.77
The use of urinary proteomics in the assessment of suitability of mouse models for ageing. PLoS One (2017) 0.75
Tomato Juice Consumption Modifies the Urinary Peptide Profile in Sprague-Dawley Rats with Induced Hepatic Steatosis. Int J Mol Sci (2016) 0.75
Diaphragmatic function is enhanced in fatty and diabetic fatty rats. PLoS One (2017) 0.75
Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease. Clin Kidney J (2017) 0.75
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest (1999) 7.35
MEROPS: the peptidase database. Nucleic Acids Res (2004) 7.27
Trends in cardiovascular complications of diabetes. JAMA (2004) 4.74
Advanced glycation endproducts--role in pathology of diabetic complications. Diabetes Res Clin Pract (2005) 3.30
Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem (2000) 3.17
Revealing the cost of Type II diabetes in Europe. Diabetologia (2002) 2.52
CutDB: a proteolytic event database. Nucleic Acids Res (2006) 2.41
Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol (2006) 2.29
COMPASS: a suite of pre- and post-search proteomics software tools for OMSSA. Proteomics (2011) 2.19
Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation (2005) 2.01
Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol (2007) 1.98
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
Fetuin-A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol (2009) 1.86
Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene. Arterioscler Thromb Vasc Biol (2003) 1.65
Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int (2005) 1.63
Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat Rev Nephrol (2010) 1.43
Urinary proteomics for early diagnosis in diabetic nephropathy. Diabetes (2012) 1.38
Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis (2006) 1.33
Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol (2006) 1.33
The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension (1989) 1.21
Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom Rev (2009) 1.19
Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals. J Hypertens (2010) 1.09
Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus. Diabetes Res Clin Pract (2006) 1.00
Urinary proteome pattern in children with renal Fanconi syndrome. Nephrol Dial Transplant (2009) 0.98
Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes. Am J Physiol Renal Physiol (2011) 0.98
The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am J Physiol Renal Physiol (2004) 0.97
Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats. J Hypertens (2010) 0.91
Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology. PLoS One (2010) 0.89
Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria. BMC Nephrol (2010) 0.85
Serum fetuin-A in metabolic and inflammatory pathways in patients with myocardial infarction. Eur J Clin Invest (2011) 0.84
Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat. PLoS One (2012) 0.82
Profiling of rat urinary proteomic patterns associated with drug-induced nephrotoxicity using CE coupled with MS as a potential model for detection of drug-induced adverse effects. Proteomics Clin Appl (2009) 0.82
The minimum information about a genome sequence (MIGS) specification. Nat Biotechnol (2008) 31.04
Taverna: a tool for building and running workflows of services. Nucleic Acids Res (2006) 14.90
Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab (2008) 9.74
Bio-ontologies: current trends and future directions. Brief Bioinform (2006) 5.96
Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med (2004) 5.04
BioCatalogue: a universal catalogue of web services for the life sciences. Nucleic Acids Res (2010) 4.67
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat Med (2011) 3.96
Phase II trial of sorafenib in metastatic thyroid cancer. J Clin Oncol (2009) 3.73
Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation (2002) 3.65
State of the nation in data integration for bioinformatics. J Biomed Inform (2008) 3.60
Development of FuGO: an ontology for functional genomics investigations. OMICS (2006) 3.59
Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab (2005) 3.47
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest (2006) 3.41
Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol (2004) 3.41
Asymmetric Rab 11 endosomes regulate delta recycling and specify cell fate in the Drosophila nervous system. Cell (2005) 2.86
Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin Appl (2007) 2.84
Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2. Immunity (2013) 2.74
MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N Engl J Med (2011) 2.65
Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells (2008) 2.51
Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol (2006) 2.29
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition. J Am Soc Nephrol (2012) 2.26
Urinary proteomics in diabetes and CKD. J Am Soc Nephrol (2008) 2.12
In-silico human genomics with GeneCards. Hum Genomics (2011) 2.10
ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease. J Clin Invest (2004) 2.08
Urine in clinical proteomics. Mol Cell Proteomics (2008) 2.05
Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol (2007) 2.02
Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol (2012) 1.90
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides. J Am Soc Nephrol (2008) 1.89
Imaging of the porous ultrastructure of the glomerular epithelial filtration slit. J Am Soc Nephrol (2010) 1.85
Data curation + process curation=data integration + science. Brief Bioinform (2008) 1.82
In vivo maturation of functional renal organoids formed from embryonic cell suspensions. J Am Soc Nephrol (2012) 1.81
Structural mechanism for lipid activation of the Rac-specific GAP, beta2-chimaerin. Cell (2004) 1.79
Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol (2007) 1.77
Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation (2009) 1.73
A systematic strategy for large-scale analysis of genotype phenotype correlations: identification of candidate genes involved in African trypanosomiasis. Nucleic Acids Res (2007) 1.73
The THAP domain: a novel protein motif with similarity to the DNA-binding domain of P element transposase. Trends Biochem Sci (2003) 1.72
Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury. J Clin Invest (2015) 1.71
Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease. Proc Natl Acad Sci U S A (2008) 1.65
Severe acute malnutrition in childhood: hormonal and metabolic status at presentation, response to treatment, and predictors of mortality. J Clin Endocrinol Metab (2014) 1.64
A bench to bedside view of uremic toxins. J Am Soc Nephrol (2008) 1.63
Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol Cell Biol (2002) 1.63
Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int (2005) 1.63
Annotation of environmental OMICS data: application to the transcriptomics domain. OMICS (2006) 1.62
Adenosine 5'-tetraphosphate is a highly potent purinergic endothelium-derived vasoconstrictor. Circ Res (2008) 1.61
Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med (2010) 1.59
Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. Rapid Commun Mass Spectrom (2004) 1.57
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl (2008) 1.57
The Study of the Effects of Diet on Metabolism and Nutrition (STEDMAN) weight loss project: Rationale and design. Contemp Clin Trials (2005) 1.57
Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J Proteome Res (2009) 1.56
Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J Am Soc Nephrol (2009) 1.54
A clinical description of extubation failure in patients with primary brain injury. Neurocrit Care (2011) 1.54
Ontology Design Patterns for bio-ontologies: a case study on the Cell Cycle Ontology. BMC Bioinformatics (2008) 1.54
In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies. Am J Pathol (2005) 1.54
Cleavage of cohesin rings coordinates the separation of centrioles and chromatids. Nat Cell Biol (2011) 1.54
Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects. Am J Physiol Renal Physiol (2012) 1.54
Using graph theory to analyze biological networks. BioData Min (2011) 1.54
Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev (2012) 1.53
Nature and mediators of parietal epithelial cell activation in glomerulonephritides of human and rat. Am J Pathol (2013) 1.53
Vascular tolerance to nitroglycerin in ascorbate deficiency. Cardiovasc Res (2008) 1.53
Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med (2006) 1.52
Detection of angiotensin II in supernatants of stimulated mononuclear leukocytes by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass analysis. Hypertension (2005) 1.52
Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res (2007) 1.52
LPA1 receptor activation promotes renal interstitial fibrosis. J Am Soc Nephrol (2007) 1.51
Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell (2008) 1.49
Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells (2010) 1.49
Treatment of chronic proteinuric kidney disease: what next? Hypertension (2009) 1.49
L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension (2004) 1.49
Analysis of the urine proteome via a combination of multi-dimensional approaches. Proteomics (2012) 1.49
Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr Nephrol (2010) 1.48
Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics (2007) 1.47
Characterisation of advanced glycation endproducts in saliva from patients with diabetes mellitus. Biochem Biophys Res Commun (2004) 1.47
Proteome-based systems biology analysis of the diabetic mouse aorta reveals major changes in fatty acid biosynthesis as potential hallmark in diabetes mellitus-associated vascular disease. Circ Cardiovasc Genet (2014) 1.44
Secretome proteomics for discovery of cancer biomarkers. J Proteomics (2010) 1.44
Urinary proteome analysis to exclude severe vesicoureteral reflux. Pediatrics (2012) 1.42
Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique. Artif Organs (2013) 1.42
Machine learning approaches for prediction of linear B-cell epitopes on proteins. J Mol Recognit (2006) 1.41
Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol (2006) 1.41
Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis. Mol Cell Proteomics (2009) 1.41
The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation (2003) 1.41
Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes. Am J Physiol Renal Physiol (2009) 1.39
Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension (2010) 1.39
Protein kinase C delta activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cells. Diabetes (2003) 1.39
Understanding and using the meaning of statements in a bio-ontology: recasting the Gene Ontology in OWL. BMC Bioinformatics (2007) 1.38
Measuring the level of activity in community built bio-ontologies. J Biomed Inform (2012) 1.38
Urinary proteomics for early diagnosis in diabetic nephropathy. Diabetes (2012) 1.38
Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev (2007) 1.36